1. Home
  2. ETON vs PDX Comparison

ETON vs PDX Comparison

Compare ETON & PDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$42.85

Market Cap

872.7M

Sector

Health Care

ML Signal

HOLD

Logo PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PDX

PIMCO Dynamic Income Strategy Fund of Beneficial Interest

HOLD

Current Price

$21.50

Market Cap

938.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETON
PDX
Founded
2017
2019
Country
United States
NY
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
872.7M
938.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ETON
PDX
Price
$42.85
$21.50
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$39.33
N/A
AVG Volume (30 Days)
524.8K
88.5K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
4.95%
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$79,950,000.00
N/A
Revenue This Year
$40.90
N/A
Revenue Next Year
$47.23
N/A
P/E Ratio
$882.80
N/A
Revenue Growth
104.94
N/A
52 Week Low
$13.78
$18.47
52 Week High
$44.91
$25.22

Technical Indicators

Market Signals
Indicator
ETON
PDX
Relative Strength Index (RSI) 69.26 58.66
Support Level $16.02 $20.67
Resistance Level N/A $21.76
Average True Range (ATR) 2.16 0.36
MACD 0.44 0.04
Stochastic Oscillator 84.11 65.13

Price Performance

Historical Comparison
ETON
PDX

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.

Share on Social Networks: